Stock data

海昌生技 (7814)

海昌生技 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$8.51M, up 4.0% from a year earlier. EPS over the last four quarters totals NT$0.14.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 海昌生技 in Insightr